Tibet Rhodiola Pharmaceutical Holding Co.SSE: 600211

Announcement on Outline of the 2025 Annual Performance Briefing

· Issued by Tibet Rhodiola Pharmaceutical Holding Co. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Summary by 6ix AI

The company addressed various investor questions during the meeting, including future dividend plans and growth drivers. The company also discussed its ongoing acquisitions and integration efforts, as well as its commitment to high dividend payouts.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Tibet Rhodiola Pharmaceutical Holding Co. on 6ix

Earlier from Tibet Rhodiola Pharmaceutical

Later from Tibet Rhodiola Pharmaceutical

All Tibet Rhodiola Pharmaceutical news releases